Gene · 4085
Papers3,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Polo-Like Kinase 1 Regulates Chromosomal Instability and Paclitaxel Resistance in Breast Cancer Cells. | J Breast Cancer | 2022 | 35775700 | PubTator, text mining | PubMed |
| Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis. | Front Immunol | 2022 | 35774795 | PubTator, text mining | PubMed |
| Identification of Hub Genes for Early Diagnosis and Predicting Prognosis in Colon Adenocarcinoma. | Biomed Res Int | 2022 | 35774271 | PubTator, text mining | PubMed |
| Disassembly of α6β4-mediated hemidesmosomal adhesions promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin to focal adhesions. | Oncogene | 2022 | 35773413 | PubTator, text mining | PubMed |
| INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma. | Biosci Rep | 2022 | 35771229 | PubTator, text mining | PubMed |
| BubR1 recruitment to the kinetochore via Bub1 enhances spindle assembly checkpoint signaling. | Mol Biol Cell | 2022 | 35767360 | PubTator, text mining | PubMed |
| A potent estrogen receptor and microtubule specific purine-benzothiazole-based fluorescent molecular probe induces apoptotic death of breast cancer cells. | Sci Rep | 2022 | 35750870 | PubTator, text mining | PubMed |
| H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol. | Genes (Basel) | 2022 | 35741781 | PubTator, text mining | PubMed |
| MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging. | Biology (Basel) | 2022 | 35741402 | PubTator, text mining | PubMed |
| In Silico Virtual Screening of Marine Aldehyde Derivatives from Seaweeds against SARS-CoV-2. | Mar Drugs | 2022 | 35736202 | PubTator, text mining | PubMed |
| ASPM and TROAP gene expression as potential malignant tumor markers. | Ann Transl Med | 2022 | 35722431 | PubTator, text mining | PubMed |
| CKAP2L, a crucial target of miR-326, promotes prostate cancer progression. | BMC Cancer | 2022 | 35715760 | PubTator, text mining | PubMed |
| KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry. | Medicine (Baltimore) | 2022 | 35713434 | PubTator, text mining | PubMed |
| Computation-Based Discovery of Potential Targets for Rheumatoid Arthritis and Related Molecular Screening and Mechanism Analysis of Traditional Chinese Medicine. | Dis Markers | 2022 | 35707715 | PubTator, text mining | PubMed |
| Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. | EClinicalMedicine | 2022 | 35706488 | PubTator, text mining | PubMed |
| Anti-tumor pharmacology of natural products targeting mitosis. | Cancer Biol Med | 2022 | 35699421 | PubTator, text mining | PubMed |
| Comprehensive analysis of gene expression profiles to identify differential prognostic factors of primary and metastatic breast cancer. | Saudi J Biol Sci | 2022 | 35677896 | PubTator, text mining | PubMed |
| In-silico and in-vitro studies on the efficacy of mangiferin against colorectal cancer. | BMC Chem | 2022 | 35672858 | PubTator, text mining | PubMed |
| CCAR2 controls mitotic progression through spatiotemporal regulation of Aurora B. | Cell Death Dis | 2022 | 35672287 | PubTator, text mining | PubMed |
| BPA disrupts meiosis I in oogonia by acting on pathways including cell cycle regulation, meiosis initiation and spindle assembly. | Reprod Toxicol | 2022 | 35667523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4085/papers?page=26